Events

Title: Autologous macrophage-based immunotherapy Induces a pro-inflammatory state in GBM tumor microenvironment - (TEM-GBM)
Type: Poster
Presenter: CMO Carlo Russo
Time: November 10-11, 9:00 AM – 8.30 PM ET

Title: Genetically-modified hematopoietic stem cells as a one-time, systemic treatment for non-hematologic disorders
Type: Oral
Presenter: Bernhard Gentner, SR-TIGET, Milan and Co-founder of Genenta
Time: October 12, 11:10 AM -1:15 PM BST

Speakers:
Pierluigi Paracchi, CEO and Co-founder Genenta Science
Carlo Russo, CMO Genenta Science

Speakers:
Pierluigi Paracchi, CEO
Carlo Russo, CMO

Presenter: 
Pierluigi Paracchi, CEO and Co-founder Genenta Science

Presenters:
Carlo Russo, CMO

Title: You Can't Get Anywhere without the CAR-t Keys or GMP Van: Why Manufacturing is Essential (panel presentation)

Presenters:
Pierluigi Paracchi, CEO
Carlo Russo, CMO
Richard Slansky, CFO

Speakers:
Pierluigi Paracchi, CEO
Carlo Russo, CMO

Round table:
Pasquale Frega (Country President & Pharma Head at Novartis)
Jodi Halpern (MD, PhD Professor of Bioethics and Ethics of Innovative Technologies, University of California, Berkeley)
Pierluigi Paracchi (Co-founder & CEO at Genenta).